Go to BioCentury homepage
Print this Print this
Welcome to BCIQ: BioCentury Online Intelligence.
Free access to this and other abridged company profiles is provided to all subscribers to SciBX: Science-Business eXchange.

Please explore the profile and if you wish to find out more about BCIQ - please Click Here

Abbott Laboratories

Print preview Print preview

(NYSE:ABT)

Collapse Summary

General Information
 Location Abbott Park, Ill.
 Region Midwest
 Country U.S.
 Business Category Pharmaceuticals
 Year Founded 1900
 Website www.abbott.com
 Development Status Market (drug) (02/27/2007)

Archive Items are loading
Collapse Summary

Pipeline Information
Disease CategoryResearchPhase IPhase I/IIPhase IIPhase II/IIIPhase IIIRegistrationApprovedMarketed
Autoimmune

-

-

-

1

-

1

-

3

8

Cancer

-

3

4

5

-

-

-

1

1

Cardiovascular

-

-

-

-

-

2

-

-

5

Diagnostic

-

-

-

-

-

-

-

7

6

Endocrine

-

1

-

-

-

-

-

-

5

Gastrointestinal

-

-

-

-

-

-

-

-

1

Genitourinary

-

-

-

-

-

-

-

-

1

Hematology

-

-

-

-

-

-

-

-

1

Infectious

5

1

-

1

1

1

1

2

4

Inflammation

-

-

-

-

-

-

1

-

-

Metabolic

-

-

-

-

-

1

2

1

5

Neurology

-

1

-

2

-

-

1

1

1

Renal

-

-

-

-

-

-

-

-

-

Transplant

-

-

-

-

-

-

-

1

-

Total

5

6

4

9

1

5

5

16

38

Pipeline Details - Originated and out-licensed products (67 records)

Product Names

Disease Category

Standard Indication

Partners

Milestones

Latest Stage of Development

Abbott Prism HCV test (Informal)

Infectious

Hepatitis

 

 

Approved

Abbott Prism HTLV-1/HTLV-II test (Informal)

Diagnostic

Infectious, Diagnostic

 

 

Approved
More

Pipeline Details - In-licensed products (29 records)

Product NamesDisease CategoryStandard IndicationIn-licensed fromMilestonesLatest Stage of DevelopmentRights

Afinion HbA1c test (Informal)

Diagnostic

Endocrine, Diagnostic

Axis-Shield plc

 

Marketed

Commercialization

AMDX (Informal), DAPD (Informal), Amdoxovir (Other)

Infectious

HIV / AIDS

RFS Pharma LLC

 

Phase II

Commercialization
More